BioSpace News Archive

Crinetics Pharmaceuticals, Inc. today announced positive results from the multiple-ascending dose (MAD) portion of a first-in-human Phase 1 clinical study of CRN04894

Visby Medical™, a leading medical diagnostic company, announced Everett Cunningham has been appointed to the company’s Board of Directors.

Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will present at the Stifel 2022 Jaws and Paws Conference at the Pierre New York Hotel in New York City on Wednesday, June 1, 2022 at 3:00 p.m. Eastern Time.

Tryp Therapeutics , Inc. (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company”), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today the appointment of Chris Ntoumenopoulos to the Company’s Board of Directors.

Together with myNEO, CureVac aims to identify specific antigens for the development of novel mRNA cancer vaccines.

Veru Inc. announced that the Company will participate in a fireside chat at the Jefferies Healthcare Conference.

Wave Life Sciences Ltd. announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the 2022 Jefferies Healthcare Conference in New York City on Wednesday, June 8, 2022, at 3:00 p.m. ET.

Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that it will host a key opinion leader (KOL) webinar on HM43239 and luxeptinib and their roles in the treatment of acute myeloid leukemia (AML) on Thursday, June 2, 2022 at 4:30 pm Eastern Time.

SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (ConformitéEuropéenne) Mark approval for SeekInClarityTM Cancer Treatment Response Monitoring Kit and is now ready to launch this test in European Union and other countries that recognize CE mark.

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, California.